Latest Prescription Drugs news
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
posted August 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
posted August 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
posted August 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Drug for Full Range of Narcolepsy Symptoms
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Setmelanotide Beneficial in Acquired Hypothalamic Obesity Related Articles
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs 
Individuals Across Races and Ethnicities Report Psoriasis as a Considerable Burden Monthly Specialist Briefings
Stay Connected
